Revolutionary Technology

Revolutionary Technology

Exploring therapeutic uses.

Simple and Intuitive

Simple and Intuitive

The Staccato® system is breath actuated, and a patient simply inhales to administer the drug dose.

Fast-acting, non-invasive delivery technology

Fast-acting, non-invasive delivery technology

Unlike injections, the Staccato® system is non-invasive.

Patient Therapy

Patient Therapy

Products for the treatment of acute and intermittent conditions.

Frontpage Slideshow | Copyright © 2006-2012 JoomlaWorks Ltd.

Alexza's Focus

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Read more about our company

Product Pipeline

We have already demonstrated that more than 200 FDA-approved compounds are feasible for delivery by the Staccato® system. Currently we have six development programs focused on six acute and intermittent conditions.

More about our Products

Recent News

The Staccato® System

See Staccato® in action

Congratulations!

Alexza congratulates its partner, Ferrer, on the commercial launch of ADASUVE® Loxapine Inhalation Powder (Staccato® Loxapine) in the EU.
See Summary of Product Characteristics Original Adasuve EU launch: See press release Adasuve launch in Spain: See press release